Genomics company, Integrated DNA Technologies, is rewriting the future of genomics, pioneering new innovations in a bold move ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...

Pioneering research led by the University of Bristol has repurposed a gene-editing tool to help shed light on the true ...

Lucia Nikolaeva-Reynolds performing targeted DNA sequencing to uncover the diversity of organisms present in a microbial ...

Plant breeding plays a vital role in ensuring global food security by increasing crop yields, improving nutritional quality ...

The Global Cell And Gene Therapy Market is valued at USD 20.5 Billion in 2024 and is projected to reach a value of USD 128.8 ...

Researchers developed a machine learning model, PAMmla, to predict properties of CRISPR-Cas9 enzymes, enhancing precision and ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions -- but there is always room for improvement. A new paper showcases the power of scalable protein ...

An expert panel will discuss the latest research on CRISPR and how to use it in biotechnology and disease research.

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...